Shandong Jincheng Pharmaceutical Group Co., Ltd (SHE:300233)

Market Cap	6.74B
Revenue (ttm)	3.16B
Net Income (ttm)	148.86M
Shares Out	379.33M
EPS (ttm)	0.39
PE Ratio	45.57
Forward PE	n/a
Dividend	0.30 (1.69%)
Ex-Dividend Date	May 14, 2025

Volume	23,954,492
Average Volume	29,060,406
Open	18.55
Previous Close	18.33
Day's Range	17.65 - 18.55
52-Week Range	10.65 - 23.22
Beta	0.46
RSI	50.09
Earnings Date	Aug 21, 2025

About Paramount Global

Shandong Jincheng Pharmaceutical Group Co., Ltd researches and develops, produces, markets, and sells Cephalosporin intermediates in China and internationally. The company offers medical intermediate, animal nutrition, health care, CMO, CDMO, pharmaceuticals, API, finished dosage, and fine chemicals. Shandong Jincheng Pharmaceutical Group Co., Ltd was founded in 2004 and is based in Zibo, China.

• Industry: Chemicals
• Sector: Materials
• Founded: 2004
• Employees: 3,657
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300233

Financial Performance

In 2024, SHE:300233's revenue was 3.37 billion, a decrease of -4.66% compared to the previous year's 3.54 billion. Earnings were 196.78 million, an increase of 12.63%.